Skip to main content

Emily Betancourt Fernández

Institutions of which they are part

Predoctoral researcher
Molecular Imaging and Therapy
Vall Hebron Institut de Recerca

Emily Betancourt Fernández

Institutions of which they are part

Predoctoral researcher
Molecular Imaging and Therapy
Vall Hebron Institut de Recerca

Projects

Resistencia a la insulina en la diabetes tipo 2: clarificando el mecanismo patogénico de la resistencia a la insulina miocárdica y los efectos de tratamientos con GLP-1 RA y SGLT2i

IP: José Raul Herance Camacho
Collaborators: Sofia Rodriguez Fernandez, Sergi Velasco Vila, Clara Ramírez Serra, Azahara Maria Palomar Muñoz, Cristina Gamez Cenzano, Jana Vidal Otero, Carolina Aparicio Gomez, Alberto Roque Pérez, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán, Maria Nazarena Pizzi, Emily Betancourt Fernández, Enrique Franky Vargas, Martha Sahylí Ortega Pijeira, Emily Betancourt Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 252500
Reference: PI24/01356
Duration: 01/01/2025 - 31/12/2027

Related news

UNCAN-Connect aims to enhance interoperability and accelerate scientific progress by supporting open science and strengthening collaborations.

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Maria Pallares Masmitja

Maria Pallares Masmitja

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Nuria Gonzalez Llorens

Nuria Gonzalez Llorens

Growth and Development
Read more
Aguado Lain, Carmen

Aguado Lain, Carmen

Shock, Organ Dysfunction and Resuscitation
Read more
Ruiz Esteve, Fernando

Ruiz Esteve, Fernando

Research technician
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.